반응식
[C:1]([O:4][C:5]1[C:21]([CH2:22][N:23]([CH2:32][C:33]([O:35][C:36]([CH3:39])([CH3:38])[CH3:37])=[O:34])[CH2:24][C:25]([O:27][C:28]([CH3:31])([CH3:30])[CH3:29])=[O:26])=[CH:20][C:8]([C:9](C2C=CC=C(C(O)=O)C=2)=[O:10])=[CH:7][C:6]=1[CH2:40][N:41]([CH2:50][C:51]([O:53][C:54]([CH3:57])([CH3:56])[CH3:55])=[O:52])[CH2:42][C:43]([O:45][C:46]([CH3:49])([CH3:48])[CH3:47])=[O:44])(=[O:3])[CH3:2].C(N1[C:72]2[C:67](=[CH:68][CH:69]=[CH:70][CH:71]=2)[CH:66]=[CH:65][CH:64]1[O:73][CH2:74]C)(OCC)=O.N[C@H](C(O)=O)C[C:79]1[CH:86]=[C:84]([I:85])[C:83]([O:87][C:88]2[CH:95]=[C:93]([I:94])[C:92]([OH:96])=[C:90]([I:91])[CH:89]=2)=[C:81]([I:82])[CH:80]=1.[O:100]1CCCC1>>[C:1]([O:4][C:5]1[C:21]([CH2:22][N:23]([CH2:32][C:33]([O:35][C:36]([CH3:38])([CH3:37])[CH3:39])=[O:34])[CH2:24][C:25]([O:27][C:28]([CH3:29])([CH3:30])[CH3:31])=[O:26])=[CH:20][C:8]([C:9]([C:71]2[CH:70]=[CH:69][CH:68]=[C:67]([CH2:66][CH:65]([C:64]([O:73][CH3:74])=[O:100])[C:79]3[CH:86]=[C:84]([I:85])[C:83]([O:87][C:88]4[CH:89]=[C:90]([I:91])[C:92]([OH:96])=[C:93]([I:94])[CH:95]=4)=[C:81]([I:82])[CH:80]=3)[CH:72]=2)=[O:10])=[CH:7][C:6]=1[CH2:40][N:41]([CH2:42][C:43]([O:45][C:46]([CH3:47])([CH3:48])[CH3:49])=[O:44])[CH2:50][C:51]([O:53][C:54]([CH3:55])([CH3:56])[CH3:57])=[O:52])(=[O:3])[CH3:2]참가 물질
5
반응물 4
생성물 1
실험 절차
A mixture of 900 mg of 20 and 0.265 g (1.07 mmol) of 1-carbethoxy-2-ethoxy-1,2-dihydroquinoline (EEDQ) in 20 mL of dry tetrahydrofuran was stirred for 30 minutes and 0.85 g (1.07 mmol) of the methyl ester of thyroxine was added. The mixture was stirred overnight. The reaction mixture was purified by gel permeation chromatography using tetrahydrofuran as the solvent, giving 630 mg of material which showed an NMR spectrum which was consistent with structure 21.
후처리
- stirringThe mixture was stirred overnight
- customThe reaction mixture was purified by gel permeation chromatography
출처 및 근거
- ORD 기록
- ord-7454a9445f7f41348a67ce5c19ea6fd0
- 출처 데이터셋
- uspto-grants-1989_01
- 특허 번호
- US04801722
연결된 노트
불러오는 중…